Figure 1

(A) Bayesian phylogenomic tree from the core genome and genomic characterization of resistance elements of 55 representative Latin American VREfm strains. The presence of a genetic element is marked by a black box in the corresponding column of the isolate. (B) Phenotypic resistance profile of 207 clinical isolates of VREfm from our Latin American collection for vancomycin (VAN), teicoplanin (TEI), ampicillin (AMP), chloramphenicol (CHL), ciprofloxacin (CIP), linezolid (LNZ), high-level resistance to gentamicin (HLR-GE) and high-level resistance to streptomycin (HLR-STR).